- Study design: Phase 1/2A double-blind, randomised, placebo-controlled trial
- Duration: 4 weeks
- Trial registration: Registered prospectively (25 October 2021) with the Australian New Zealand Clinical Trials Registry, ACTRN12621001441808p
- Ethics approval: Bellberry Human Research Ethics Committee, Australia (2021-09-1137)
Citation
Patch, C.; Pearce, A.J.; Cheng, M.; Boyapati, R.; Brenna, J.T. Bacillus Subtilis (BG01-4™) Improves Self-Reported Symptoms for Constipation, Indigestion, and Dyspepsia: A Phase 1/2A Randomized Controlled Trial. Nutrients 2023, 15, 4490. https://doi.org/10.3390/nu15214490